|
¹Ì±¹ÀÇ Àν¶¸° ÁÖ»ç±â ½ÃÀå ºÐ¼®
US Market Report for Insulin Syringes 2017 - MedCore
|
¸®¼Ä¡»ç |
iData Research Inc.
|
¹ßÇàÀÏ |
2016³â 11¿ù |
»óǰ ÄÚµå |
392597 |
ÆäÀÌÁö Á¤º¸ |
¿µ¹® 56 Pages |
°¡°Ý |
|
¹Ì±¹ÀÇ Àν¶¸° ÁÖ»ç±â ½ÃÀå ºÐ¼®
US Market Report for Insulin Syringes 2017 - MedCore
|
¹ßÇàÀÏ : 2016³â 11¿ù | ÆäÀÌÁö Á¤º¸ : ¿µ¹® 56 Pages |
|
|
¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹®¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¹Ì±¹ÀÇ Àν¶¸° ÁÖ»ç±â(Insulin Syringes) ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, ÀüüÀûÀÎ ½ÃÀå ±Ô¸ð µ¿Çâ Àü¸Á, Á¦Ç°º° µ¿Çâ, ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, ÃÖ±ÙÀÇ ½ÃÀå ±¸µµ, ±â¾÷º° ½ÃÀå Á¡À¯À², ½ÃÀå ¹è°æ(°ü·Ã Áúȯ ¹× Á¦Ç° °³¿ä, ȯÀÚ¼ö µî) µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
1. °³¿ä
2. ¹Ì±¹ÀÇ ´ç´¢º´ ¸ð´ÏÅ͸µ, Ä¡·á, ¾à¹° Àü´Þ ½ÃÀå : °³¿ä
3. °æÀï ºÐ¼®
4. ±â¾÷ µ¿Çâ
5. ±â¾÷ÀÇ ¹ßÀü
6. óġ °Ç¼ö
7. ºÐ¼® ´ë»ó óġ ÄÚµå
8. ºÐ¼® ´ë»ó ½ÃÀå
9. ÁÖ¿ä ¸®Æ÷Æ® ¾÷µ¥ÀÌÆ®
10. Version History
11. ºÐ¼® ¹æ¹ý
- ºÐ¼® ¹üÀ§
- IDATAÀÇ 9´Ü°è ºÐ¼® ¹æ¹ý
12. Áúȯ °³¿ä
- ¼·Ð
- ´ç´¢º´ÀÇ Á¾·ù
- ´ç´¢ ÇÕº´Áõ
- 1Çü¡¤2Çü ´ç´¢º´ °ü·Ã À§ÇèÀÎÀÚ
- ¡ÈÄ¿Í Áõ»ó
- ´ç´¢º´ ¸ð´ÏÅ͸µ
- Ä¡·á
- ¾à¹° Àü´Þ ½Ã½ºÅÛ
13. Àν¶¸° ÁÖ»ç±â ½ÃÀå
- ¼·Ð
- ½ÃÀå °³¿ä
- ½ÃÀå ºÐ¼®°ú ¿¹Ãø
- Àν¶¸° ÁÖ»ç±â ½ÃÀå Àüü
- ±âÁ¸ Àν¶¸° ÁÖ»ç±â ½ÃÀå
- Àν¶¸° ¾ÈÀü ÁÖ»ç±â ½ÃÀå
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ±â¾÷º° ½ÃÀå Á¡À¯À² ºÐ¼®
14. ¾à¾î ¸ñ·Ï
15. µµÇ¥
LSH 16.12.05
The U.S. insulin syringe market can be segmented by syringe type, yielding two segments: conventional insulin syringes and safety insulin syringes. In 2016, the largest segment in the total insulin syringe market was the conventional insulin syringe segment. Although conventional insulin syringes were once a popular method of insulin delivery, patients are transitioning towards new technologies such as insulin pens and pumps. Unit sales will continue to decline over the forecast period in conjunction with the growing penetration rate of insulin pens, as well as the growing penetration rate of insulin pumps among the type 2 insulin-dependent patient population. Mild ASP depreciation will also contribute to erosion in the value of the conventional insulin syringe market.
TABLE OF CONTENTS
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
- 1.1. RESEARCH SCOPE
- 1.2. IDATA'S 9-STEP METHODOLOGY
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
- 2.1. INTRODUCTION
- 2.1.1. Types of Diabetes
- 2.1.2. Diabetes Complications
- 2.1.3. Risk Factors Associated with Type 1 and Type 2 Diabetes
- 2.1.4. Signs and Symptoms
- 2.1.5. Diabetes Monitoring
- 2.1.6. Treatment
- 2.1.7. Drug Delivery Systems
INSULIN SYRINGE MARKET
- 3.1. INTRODUCTION
- 3.2. MARKET OVERVIEW
- 3.3. MARKET ANALYSIS AND FORECAST
- 3.3.1. Total Insulin Syringe Market
- 3.3.1.1. Conventional Insulin Syringe Market
- 3.3.1.2. Safety Insulin Syringe Market
- 3.4. DRIVERS AND LIMITERS
- 3.4.1. Market Drivers
- 3.4.2. Market Limiters
- 3.5. COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
LIST OF CHARTS
- Chart 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013-2023
- Chart 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023
- Chart 3-1: Insulin Syringe Market by Segment, U.S., 2013-2023
- Chart 3-2: Insulin Syringe Market Breakdown, U.S., 2016
- Chart 3-3: Insulin Syringe Market Breakdown, U.S.,2023
- Chart 3-4: Total Insulin Syringe Market, U.S., 2013-2023
- Chart 3-5: Conventional Insulin Syringe Market, U.S., 2013-2023
- Chart 3-6: Safety Insulin Syringe Market, U.S., 2013-2023
- Chart 3-7: Leading Competitors, Insulin Syringe Market, U.S., 2016
LIST OF FIGURES
- Figure 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016(1 of 2)
- Figure 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016(2 of 2)
- Figure 1-3: Companies Researched in this Report, U.S., 2016
- Figure 1-4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S.(1 of 2)
- Figure 1-5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S.(2 of 2)
- Figure 1-6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013-2016
- Figure 1-7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016
- Figure 1-8: Procedure Codes Investigated, U.S., 2016
- Figure 1-9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016(1 of 2)
- Figure 1-10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016(2 of 2)
- Figure 1-11: Key Report Updates
- Figure 1-12: Version History
- Figure 2-1: Major Types of Diabetes and Related Pathologies, U.S., 2016
- Figure 2-2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016
- Figure 2-3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016
- Figure 3-1: Insulin Syringe Market by Segment, U.S., 2013-2023(US$M)
- Figure 3-2: Total Insulin Syringe Market, U.S., 2013-2023
- Figure 3-3: Conventional Insulin Syringe Market, U.S., 2013-2023
- Figure 3-4: Safety Insulin Syringe Market, U.S., 2013-2023
- Figure 3-5: Drivers and Limiters, Insulin Syringe Market, U.S., 2016
- Figure 3-6: Leading Competitors, Insulin Syringe Market, U.S., 2016
|

|
BRIC ±¹°¡ÀÇ ´ç´¢º´ Ä¡·á±â±â ½ÃÀå ¿¹Ãø(-2025³â) : Á¾·ùº°(SMBG, CGMS, ¶õ¼Â, Àν¶¸° ÆßÇÁ, Àν¶¸° Ææ, Àν¶¸° ÁÖ»ç±â, ¸ð¹ÙÀÏ ¾Û), Ä¡·á ȯ°æº°(º´¿ø¡¤Àü¹® Ŭ¸®´Ð, ÀÚ±â Ä¡·á¡¤ÀçÅà ġ·á), ±¹°¡º°(ºê¶óÁú, ·¯½Ã¾Æ, Àεµ, Áß±¹)
¼¼°èÀÇ Àν¶¸° Àü´Þ ±â±â ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Á¾·ùº°(Àν¶¸° Ææ, Àν¶¸° ÆßÇÁ, Àν¶¸° ÁÖ»ç±â, Ææ ´Ïµé µî), ÃÖÁ¾»ç¿ëÀÚº°(ȯÀÚ/ÀçÅÃÄ¡·á, º´¿ø ¹× Áø·á¼Ò), Áö¿ªº°
¼¼°èÀÇ Àν¶¸° Àü´Þ ±â±â ½ÃÀå : ½ÃÀå ½Ã³ª¸®¿À, ½ÃÀå ±Ô¸ð, Àü¸Á, µ¿Çâ, ¿¹Ãø
¼¼°èÀÇ Àν¶¸° Àü´Þ ±â±â ½ÃÀå ¿¹Ãø(-2021³â) : Á¾·ùº°(Àν¶¸° Ææ, Àν¶¸° ÆßÇÁ, Ææ ÁÖ»çħ, Àν¶¸° ÁÖ»ç±â), ÃÖÁ¾»ç¿ëÀÚº°(ȯÀÚ ÀÚ½Å/ÀçÅà ÀÇ·á, º´¿ø ¹× Áø·á¼Ò)
À¯·´ÀÇ Àν¶¸° ÁÖ»ç±â ½ÃÀå
|